Human umbilical cord-derived mesenchymal stem cell therapy (Yixing Pharma)

人脐带间充质干细胞（毅行医药）

Report date: 2026/01/07 11:33:24

Base Information

Drug NameHuman umbilical cord-derived mesenchymal stem cell therapy (Yixing Pharma)
Drug Alias NameYX3D-01 人脐带间充质干细胞注射液YX3D-01YX3D01
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesYixing Pharmaceutical Research and Development (Qinhuangdao Beidaihe District) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesYixing Pharmaceutical Research and Development (Qinhuangdao Beidaihe District) Co Ltd
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A